"BJUI provides the very highest standard of research and clinical information for the urological community. It also promotes awareness of new advances and supports the best practice in urology with a truly international range of published papers.
Editor: Dr. Freddie Hamdy"
The online peer-reviewed complement to Journal of Endourology, offers high-caliber video demonstrations of the latest surgical techniques and technologies. Included with your subscription to Journal of Endourology.
"Neurourology and Urodynamics journals provides info from all parts of the world on topics related to upper and lower urinary tract , urinary and fecal continence, pelvic floor function and sexual dysfunction.
Editor: Roger Dmochowski"
"The Prostate is a peer-reviewed journal dedicated to original studies on Prostate and the male accessory glands. It presents comprehensive coverage of clinical, endocrinologic, and biochemical studies and significant case descriptions.
Editor: Dr. Samuel Denmeade"
"LUTS provides new clinical and basic science information to physicians and researchers in the field of neurourology, urodynamics and urogynecology. It covers both basic and clinical research on lower urinary tract dysfunctions (LUTD) as well as on other relevant conditions.
Editor: Dr. Hidehiro Kakizaki"
Huri HZ and co-authors conducted a study in a tertiary medical center in Kuala Lumpur, Malaysia, wherein a total of 200 erectile dysfunction (ED) patients with 499 cases who had received pharmacological treatments for their ED participated in this study. Types, causes and factors associated with drug-related problems (DRPs) in ED patients with multiple comorbidities were evaluated.
Bray R and co-authors evaluated the effect of tolterodine extended release (TER) versus placebo on bladder wall thickness (BWT) using transvaginal ultrasound in women with overactive bladder (OAB). They recruited 79 women with symptoms of OAB with a mean age of 47 years who had a BWT of at least 5 mm and a post-micturition volume of less than 50 mL at screening.
Lower urinary tract symptoms (LUTS) are one of the most common health problems in men and pose a significant economic challenge in healthcare. Transurethral resection of the prostate (TURP) remains the gold standard surgical treatment for medically refractive LUTS secondary to benign prostatic hyperplasia (BPH).
Kim and co-authors conducted a prospective, multi-centre clinical study to identify incidence and risk factors of recurrence after discontinuation of successful antimuscarinic therapy in patients with overactive bladder (OAB). Patients who had antimuscarinic agents for > 12 weeks and showed successful response were included.